Marilena Vrana/LinkedIn
Dec 15, 2025, 13:04
Ahead of IPPC2026: Marilena Vrana Reflects on Powering Possibility for All Patients
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
“Why do collective strength and shared responsibility matter more than ever to power possibility for all patients?
Ahead of IPPC2026 (April 28-29, Milan), this article reflects on where we stand today and the issues that will shape discussion as we look ahead.
Meet me in Milan to continue the conversation”
Get the latest hemostasis insights with Hemostasis Today.
-
Jun 29, 2026, 20:09Mamta Soni: The Role of Anti-Xa Monitoring in Anticoagulation Management
-
Jun 29, 2026, 20:07Nita Radhakrishnan: Discussing Risks, Benefits, and Uncertainties in Hemoglobinopathy Care
-
Jun 29, 2026, 20:05Anisha Navkudkar: TMH Blood Centre Received the Ravi Reddy Award 2026 at ISBT Congress
-
Jun 29, 2026, 20:03Anirban Sen Gupta: Congratulations Christopher Delianides for a Fantastic Dissertation and Graduate Research Presentation
-
Jun 29, 2026, 20:01May Guo: Inhibiting Anti-PEG Antibody Binding With Randomized PEG
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice